**Question:** Deficiency of enzyme a-keto acid decarboxylase leading to a block in the metabolism of branch chain amino acids is observed in

A. Maple Syrup Urine Disease
B. Ketogenic Diet
C. Phenylketonuria
D. Tyrosinemia

**Correct Answer:** A. Maple Syrup Urine Disease

**Core Concept:**
A-Ketone Acid Decarboxylase Enzymes and Branch Chain Amino Acids Metabolism

Branch chain amino acids are essential amino acids composed of isoleucine, leucine, and valine. These amino acids are catabolized in the liver via the action of specific enzymes, including a-keto acid decarboxylase enzymes (BCKD complex). The BCKD complex consists of four subunits: BCKDH, DBT, E1α, and E1β. These enzymes are crucial for the proper breakdown of branch chain amino acids, ultimately leading to the production of energy in the form of acetyl-CoA.

**Why the Correct Answer is Right:**
In Maple Syrup Urine Disease (MSUD), there is a deficiency in the BCKD complex. Specifically, the deficiency is caused by mutations in the DBT gene which encodes for dihydrolipoamide branched chain transacylase (D-ICDH) subunit of the BCKD complex. This deficiency leads to a block in the decarboxylation of a-keto acids, including leucine, isoleucine, and valine. This results in the accumulation of a-keto acids and their derivatives, causing the characteristic odor of urine similar to maple syrup.

**Why Each Wrong Option is Incorrect:**

A. Ketogenic Diet: This is a dietary therapy used in epilepsy management, not a genetic disorder. The ketogenic diet does not affect the BCKD complex or branch chain amino acids.

B. Phenylketonuria (PKU): PKU is caused by a deficiency in phenylalanine hydroxylase, which results in phenylalanine accumulation. It is unrelated to the BCKD complex or branch chain amino acids.

C. Tyrosinemia: Tyrosinemia is caused by mutations in tyrosine hydroxylase, leading to tyrosine accumulation, not a-keto acid decarboxylase deficiency. Tyrosinemia is unrelated to the BCKD complex or branch chain amino acids.

**Clinical Pearls:**
1. MSUD is a rare autosomal recessive disorder, typically presenting in infants with neurological symptoms, such as lethargy, failure to thrive, and seizures.
2. MSUD is managed through a specialized diet that restricts branched-chain amino acids to reduce the accumulation of a-keto acids and prevent neurological complications.
3. Early diagnosis and intervention are crucial for improving the prognosis and preventing irreversible neurological damage in MSUD patients.